Leading the
small molecule
Revolution

We combine the power of chemoproteomics and covalent chemistry to forge life-changing connections between precision therapeutics and previously undrugged drivers of disease.

Leading
the small
molecule
Revolution

We combine the power of chemoproteomics and covalent chemistry to forge life-changing connections between precision therapeutics and previously undrugged drivers of disease.

Committed to patient impact


Our drug discovery engine has yielded multiple novel drug candidates that are being evaluated in clinical trials.

Transforming drug discovery


Chemoproteomics provides the lens for an expansive view of the human proteome that enables us to find novel ways to develop small molecules with therapeutic potential. 

Vividion’s unique chemoproteomics platform allows us to identify and pursue novel strategies to target pathways that contribute to human disease. One of the most rewarding aspects of this drug discovery approach is the ability to explore hypotheses related to our therapeutic strategies, in hopes of finding the optimal ways to bring our treatments to patients.”

-Joseph Klebba, Ph.D., Associate Director, Oncology Early Discovery Sciences

Joseph Klebba

Associate Director, Oncology Early Discovery Sciences